JPMorgan Chase & Co. Issues Pessimistic Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lowered by equities research analysts at JPMorgan Chase & Co. from $950.00 to $800.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price target would indicate […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lowered by equities research analysts at JPMorgan Chase & Co. from $950.00 to $800.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price target would indicate […]
